Clinical Trial

Assessing Pain by the painDETECT Questionnaire (PDQ)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Prospective cohort study using drug survival rates to assess the predictive value of the PDQ when used to classify patients into a non-neuropathic pain phenotype group (score \<13) or a neuropathic pain phenotype group (score ≥13)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-02; most recent amendment 2025-05-14.
Trial Details
NCT Number NCT06402396
Lead Sponsor University Hospital Bispebjerg and Frederiksberg
Conditions Inflammatory Arthritis, Spondylarthropathies, Rheumatoid Arthritis, Psoriatic Arthritis
Enrollment 7,056 participants
Start Date 2013-01
Primary Completion 2019-12-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-20